EDGAR Filing Documents for 0001104659-12-047042

Form 8-K - Current report:

SEC Accession No. 0001104659-12-047042

Filing Date

2012-06-29

Accepted

2012-06-29 17:20:57

Documents

Period of Report

2012-06-25

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	a12-15637_18k.htm	8-K	47349
2	EX-10.1	a12-15637_1ex10d1.htm	EX-10.1	86753
3	EX-10.2	a12-15637_1ex10d2.htm	EX-10.2	70503
4	EX-10.3	a12-15637_1ex10d3.htm	EX-10.3	70989
5	EX-99.1	a12-15637_1ex99d1.htm	EX-99.1	17083
6	EX-99.2	a12-15637_1ex99d2.htm	EX-99.2	23206
7	GRAPHIC	g156371kli001.jpg	GRAPHIC	2415
8	GRAPHIC	g156371kli002.gif	GRAPHIC	73
9	GRAPHIC	g156371mmi001.jpg	GRAPHIC	2257
10	GRAPHIC	g156371moi001.jpg	GRAPHIC	2257
11	GRAPHIC	g156371kmi001.jpg	GRAPHIC	2415
12	GRAPHIC	g156371kmi002.gif	GRAPHIC	73
	Complete submission text file	0001104659-12-047042.txt		331308

Mailing Address 100 HAYDEN AVENUE LEXINGTON MA 02421

Business Address 100 HAYDEN AVENUE LEXINGTON MA 02421 6174983300

AMAG PHARMACEUTICALS INC. (Filer) CIK: 0000792977 (see all company filings)